Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

I think there is zero chance of analyst upgrades with the status quo. If Helen doesn't impress in the next call we may even see some dopwngrades to "Hold" or worse. The most she has acomplished in the last few years is to put HALO $800 million in debt with nothing to show for it. (And, in anticipation of what some others may say, no, it's not "free money" so don't even try that with me. LOL!)